摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(5-甲基-1,2-恶唑-3-基)-1-(4-硝基苯基)甲亚胺 | 112633-39-3

中文名称
N-(5-甲基-1,2-恶唑-3-基)-1-(4-硝基苯基)甲亚胺
中文别名
——
英文名称
(E)-N-(5-Methyl-1,2-oxazol-3-yl)-1-(4-nitrophenyl)methanimine
英文别名
N-(5-methyl-1,2-oxazol-3-yl)-1-(4-nitrophenyl)methanimine
N-(5-甲基-1,2-恶唑-3-基)-1-(4-硝基苯基)甲亚胺化学式
CAS
112633-39-3
化学式
C11H9N3O3
mdl
——
分子量
231.211
InChiKey
FSNLLGSNBWLZNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    117-119 °C
  • 沸点:
    441.0±40.0 °C(Predicted)
  • 密度:
    1.33±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    84.2
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    N-(5-甲基-1,2-恶唑-3-基)-1-(4-硝基苯基)甲亚胺三乙酰氧基硼氢化钠 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 3.5h, 以1.62 g的产率得到N-(4'-nitro)benzyl-N-(5-methyl-3-isoxazolyl)amine
    参考文献:
    名称:
    Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists
    摘要:
    Modulation of the transient receptor potential melastatin type-8 (TRPM8), the receptor for menthol acting as the major sensor for peripheral innocuous cool temperatures, has several important applications in pharmaceutical, food and cosmetic industries. In the present study, we designed 12 isoxazole derivatives and tested their pharmacological properties both in F11 sensory neurons in vitro, and in an in vivo model of cold allodynia. In F11 sensory neurons, single-cell ca(2+)-imaging experiments revealed that, when compared to menthol, some newly-synthesized compounds were up to 200-fold more potent, though none of them showed an increased efficacy. Some isoxazole derivatives potentiated allodynic responses elicited by acetone when administered to rats subjected to sciatic nerve ligation; when compared to menthol, these compounds were efficacious at earlier (0-2 min) but not later (7-9 or 14-16 min) time points. Docking experiments performed in a human TRPM8 receptor model revealed that newly-synthesized compounds might adopt two possible conformations, thereby allowing to distinguish "menthol-like" compounds (characterized by high efficacy/low potency), and "icillin-like" compounds (with high potency/low efficacy). Collectively, these data provide rationale structure-activity relationships for isoxazole derivatives acting as TRPM8 agonists, and suggest their potential usefulness for cold-evoked analgesia. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.08.056
  • 作为产物:
    参考文献:
    名称:
    氨基异恶唑和芳香醛反应的异常产物
    摘要:
    摘要 伯胺与醛反应通常会产生席夫碱。在这项工作中,我们介绍了在 5-甲基-3-氨基异恶唑 (3AMI) 或 3-甲基-5-反应中获得的产物的研究结果(NMR、ATR-FTIR、UV-Vis 和 X 射线)氨基异恶唑 (5AMI) 与 17 种不同的醛。基于结果,我们证明了这种简单而众所周知的反应并不总是导致获得典型的产品。此外,我们还讨论了所研究的邻羟基亚胺化合物在溶液和固态中优选的互变异构形式。了解赋予席夫碱的互变异构形式存在于溶液中和固态中,对于医学和药学以及配位化学的发展非常重要。
    DOI:
    10.1016/j.molstruc.2021.131320
点击查看最新优质反应信息

文献信息

  • New tricks of well-known aminoazoles in isocyanide-based multicomponent reactions and antibacterial activity of the compounds synthesized
    作者:Maryna V Murlykina、Maryna N Kornet、Sergey M Desenko、Svetlana V Shishkina、Oleg V Shishkin、Aleksander A Brazhko、Vladimir I Musatov、Erik V Van der Eycken、Valentin A Chebanov
    DOI:10.3762/bjoc.13.104
    日期:——
    novel features of a Groebke-Blackburn-Bienaymé cyclocondensation are established and discussed. The heterocycles obtained were evaluated for their antibacterial activity and several of them demonstrated a weak antimicrobial effect, but for most of the compounds a 30-50% increase in biomass of Gram-positive strains (mainly B. subtilis) compared to control was observed.
    在 Ugi 和 Groebke-Blackburn-Bienaymé 多组分反应中,对著名的氨基唑、3-氨基-5-甲基异恶唑和 5-氨基-N-芳基-1H-吡唑-4-甲酰胺作为胺组分进行了研究。发现了氨基唑在 Ugi 四组分反应中应用的第一个例子,并建立并讨论了 Groebke-Blackburn-Bienaymé 环缩合的新特征。对获得的杂环化合物的抗菌活性进行了评估,其中一些化合物显示出较弱的抗菌作用,但对于大多数化合物而言,观察到与对照相比,革兰氏阳性菌株(主要是枯草芽孢杆菌)的生物量增加了 30-50%。
  • Squaramide-catalysed enantionselective Mannich reaction of imines bearing a heterocycle with malonates
    作者:Hai-Xiao He、Da-Ming Du
    DOI:10.1039/c3ra43260b
    日期:——
    An efficient enantioselective Mannich reaction of imines bearing a heterocycle with malonates catalysed by a cinchona-based squaramide organocatalyst has been developed. This catalytic asymmetric reaction afforded the β-amino ester derivatives containing a heterocycle moiety in high yields (up to 99%) and excellent enantioselectivities (up to 98%) in most cases. The imines with an electron-withdrawing
    已经开发了一种有效的对映选择性曼尼奇反应,该亚胺带有一个由金鸡纳基方酸酰胺有机催化剂催化的丙二酸酯。该催化不对称反应在大多数情况下以高产率(高达99%)和优异的对映选择性(高达98%)提供了含有杂环部分的β-氨基酯衍生物。在该反应中,具有吸电子基团的亚胺比带有电子给体基团的亚胺具有更好的收率。
  • Synthesis and antidiabetic performance of β-amino ketone containing nabumetone moiety
    作者:Hang Wang、Ju-fang Yan、Xiao-li Song、Li Fan、Jin Xu、Guang-ming Zhou、Li Jiang、Da-cheng Yang
    DOI:10.1016/j.bmc.2012.01.028
    日期:2012.3
    We wish to report the further design and improved synthesis that resulted in two series of target molecules, TM-1 and TM-2, with remarkably simplified structures containing beta-amino ketone of discrete nabumetone moiety. These were obtained via a 'one-pot, two-step, three-component' protocol of Mannich reaction with yield up to 97%. A total of 28 out of 31 new compounds were characterized using H-1 NMR, C-13 NMR, ESI MS and HRMS techniques. Studies on their antidiabetic activities, screened in vitro at 10 mu g mL (1) level, indicate that TM-2 possesses peroxisome proliferator-activated receptor activation and alpha-glucosidase inhibition activity significantly stronger than that of TM-1, and also that of the series B compounds that were previously synthesized by the group. Analysis of the structure-activity relationship points to the sulfanilamide unit as the most probable potent group of b-amino ketone and, on the basis of which, a tangible strategy is presented for the development of new antidiabetic drugs. (C) 2012 Elsevier Ltd. All rights reserved.
  • Rajanarendar; Raju; Reddy, M. Nagi, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2011, vol. 50, # 2, p. 223 - 228
    作者:Rajanarendar、Raju、Reddy, M. Nagi、Reddy, K. Govardhan
    DOI:——
    日期:——
  • Rajanarendar; Afzal; Ramu, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2003, vol. 42, # 4, p. 927 - 930
    作者:Rajanarendar、Afzal、Ramu
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐